Literature DB >> 23760655

Nemorosone and its emerging anti-neoplastic effects.

Shailendra Kapoor1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23760655     DOI： 10.1007/s00417-013-2395-3

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN： 0721-832X            Impact factor:   3.117


× No keyword cloud information.
  6 in total

1.  Chemosensitivity of conjunctival melanoma cell lines to target-specific chemotherapeutic agents.

Authors:  Henrike Westekemper; Michael Freistuehler; Norbert Bornfeld; Klaus-Peter Steuhl; Max Scheulen; Ralf A Hilger
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-07-11       Impact factor: 3.117

2.  Cytotoxic activity of nemorosone in human MCF-7 breast cancer cells.

Authors:  Ada Popolo; Anna Lisa Piccinelli; Silvana Morello; Rosalinda Sorrentino; Cuesta Rubio Osmany; Luca Rastrelli; Aldo Pinto; Pinto Aldo
Journal:  Can J Physiol Pharmacol       Date:  2011-01       Impact factor: 2.273

3.  Microarray analysis of nemorosone-induced cytotoxic effects on pancreatic cancer cells reveals activation of the unfolded protein response (UPR).

Authors:  Frank Holtrup; Andrea Bauer; Kurt Fellenberg; Ralf A Hilger; Michael Wink; Jörg D Hoheisel
Journal:  Br J Pharmacol       Date:  2011-03       Impact factor: 8.739

4.  Nemorosone blocks proliferation and induces apoptosis in leukemia cells.

Authors:  D Díaz-Carballo; S Malak; M Freistühler; A Elmaagacli; W Bardenheuer; H P Reusch
Journal:  Int J Clin Pharmacol Ther       Date:  2008-08       Impact factor: 1.366

5.  7-epi-nemorosone from Clusia rosea induces apoptosis, androgen receptor down-regulation and dysregulation of PSA levels in LNCaP prostate carcinoma cells.

Authors:  David Díaz-Carballo; Sebastian Gustmann; Ali Haydar Acikelli; Walter Bardenheuer; Helmut Buehler; Holger Jastrow; Suleyman Ergun; Dirk Strumberg
Journal:  Phytomedicine       Date:  2012-09-14       Impact factor: 5.340

6.  Cytotoxic activity of nemorosone in neuroblastoma cells.

Authors:  D Díaz-Carballo; S Malak; W Bardenheuer; M Freistuehler; H P Reusch
Journal:  J Cell Mol Med       Date:  2008-12       Impact factor: 5.310
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.